drugset / Trial / NCT05225545

Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis

NCT05225545

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to compare the tolerability and efficacy of Sucrosomial Iron to Oral Iron Therapy in a randomized controlled trial for the treatment of Iron Deficiency Anemia in Ulcerative Colitis patients.

Timeline

Start
2019-11-04
Primary completion
2024-05-04
Completion
2024-05-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 195 mg Oral
Subject Sucrosomial Iron Unknown 30 mg